Feedback / Questions
ABBV-230 - AbbVie
https://www.globenewswire.com/news-release/2025/12/08/3201201/0/en/OSE-Immunotherapeutics-Announces-Strategic-Amendment-to-AbbVie-s-Partnership-on-ABBV-230-Development.html
Dec 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next